| pubmed-article:16835281 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16835281 | lifeskim:mentions | umls-concept:C0029453 | lld:lifeskim |
| pubmed-article:16835281 | lifeskim:mentions | umls-concept:C1504389 | lld:lifeskim |
| pubmed-article:16835281 | lifeskim:mentions | umls-concept:C0043603 | lld:lifeskim |
| pubmed-article:16835281 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:16835281 | lifeskim:mentions | umls-concept:C1515895 | lld:lifeskim |
| pubmed-article:16835281 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:16835281 | pubmed:dateCreated | 2006-10-9 | lld:pubmed |
| pubmed-article:16835281 | pubmed:abstractText | Rapid bone loss occurs from the proximal femur after allogeneic stem cell transplantation (alloSCT). Objective: The objective of the study was to evaluate effects of high-dose pamidronate therapy on bone loss (BMD) after alloSCT. | lld:pubmed |
| pubmed-article:16835281 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16835281 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16835281 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16835281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16835281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16835281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16835281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16835281 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16835281 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:16835281 | pubmed:issn | 0021-972X | lld:pubmed |
| pubmed-article:16835281 | pubmed:author | pubmed-author:ReynoldsJJ | lld:pubmed |
| pubmed-article:16835281 | pubmed:author | pubmed-author:HugEE | lld:pubmed |
| pubmed-article:16835281 | pubmed:author | pubmed-author:SvábZZ | lld:pubmed |
| pubmed-article:16835281 | pubmed:author | pubmed-author:HerrmannRR | lld:pubmed |
| pubmed-article:16835281 | pubmed:author | pubmed-author:BradstockKK | lld:pubmed |
| pubmed-article:16835281 | pubmed:author | pubmed-author:EbelingP RPR | lld:pubmed |
| pubmed-article:16835281 | pubmed:author | pubmed-author:SchwarerA PAP | lld:pubmed |
| pubmed-article:16835281 | pubmed:author | pubmed-author:GriggA PAP | lld:pubmed |
| pubmed-article:16835281 | pubmed:author | pubmed-author:ShuttleworthP... | lld:pubmed |
| pubmed-article:16835281 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16835281 | pubmed:volume | 91 | lld:pubmed |
| pubmed-article:16835281 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16835281 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16835281 | pubmed:pagination | 3835-43 | lld:pubmed |
| pubmed-article:16835281 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16835281 | pubmed:meshHeading | pubmed-meshheading:16835281... | lld:pubmed |
| pubmed-article:16835281 | pubmed:meshHeading | pubmed-meshheading:16835281... | lld:pubmed |
| pubmed-article:16835281 | pubmed:meshHeading | pubmed-meshheading:16835281... | lld:pubmed |
| pubmed-article:16835281 | pubmed:meshHeading | pubmed-meshheading:16835281... | lld:pubmed |
| pubmed-article:16835281 | pubmed:meshHeading | pubmed-meshheading:16835281... | lld:pubmed |
| pubmed-article:16835281 | pubmed:meshHeading | pubmed-meshheading:16835281... | lld:pubmed |
| pubmed-article:16835281 | pubmed:meshHeading | pubmed-meshheading:16835281... | lld:pubmed |
| pubmed-article:16835281 | pubmed:meshHeading | pubmed-meshheading:16835281... | lld:pubmed |
| pubmed-article:16835281 | pubmed:meshHeading | pubmed-meshheading:16835281... | lld:pubmed |
| pubmed-article:16835281 | pubmed:meshHeading | pubmed-meshheading:16835281... | lld:pubmed |
| pubmed-article:16835281 | pubmed:meshHeading | pubmed-meshheading:16835281... | lld:pubmed |
| pubmed-article:16835281 | pubmed:meshHeading | pubmed-meshheading:16835281... | lld:pubmed |
| pubmed-article:16835281 | pubmed:meshHeading | pubmed-meshheading:16835281... | lld:pubmed |
| pubmed-article:16835281 | pubmed:meshHeading | pubmed-meshheading:16835281... | lld:pubmed |
| pubmed-article:16835281 | pubmed:meshHeading | pubmed-meshheading:16835281... | lld:pubmed |
| pubmed-article:16835281 | pubmed:meshHeading | pubmed-meshheading:16835281... | lld:pubmed |
| pubmed-article:16835281 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16835281 | pubmed:articleTitle | Pamidronate reduces bone loss after allogeneic stem cell transplantation. | lld:pubmed |
| pubmed-article:16835281 | pubmed:affiliation | Department of Medicine, University of Melbourne, Western Hospital, Footscray 3011, Australia. | lld:pubmed |
| pubmed-article:16835281 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16835281 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16835281 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16835281 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16835281 | lld:pubmed |
